C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis-Reference-Cited by-同舟云学术

C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis

Published:2020-07-12 Issue:12 Volume:61 Page:2969-2974
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lucijanic Marko¹^ORCID,Galusic Davor²,Krecak Ivan³^ORCID,Sedinic Martina¹,Soric Ena¹,Holik Hrvoje⁴,Perisa Vlatka⁵⁶,Moric Peric Martina⁷,Zekanovic Ivan⁷,Stoos-Veic Tajana⁸⁹,Kusec Rajko¹⁹

Affiliation:

1. Hematology Department, University Hospital Dubrava, Zagreb, Croatia

2. Department of Hematology, University Hospital of Split, Split, Croatia

3. Hematology Department, General Hospital Sibenik, Sibenik, Croatia

4. Department of Internal Medicine, “Dr. Josip Bencevic” General Hospital, Ul. Andrije Štampara, Slavonski Brod, Croatia

5. Department of Hematology, Osijek University Hospital, Osijek, Croatia

6. Faculty of Medicine, University of Osijek, Osijek, Croatia

7. Department of Internal Medicine, General Hospital Zadar, Zadar, Croatia

8. Department of Clinical Cytology and Cytometry, University Hospital Dubrava, Zagreb, Croatia

9. School of Medicine, University of Zagreb, Zagreb, Croatia

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1789627

Reference19 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement

3. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?

4. Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis

5. Primary myelofibrosis: Older age and high JAK2 V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of the Predictive Value of Biomarkers in Sepsis Mortality;Emergency Medicine International;2024-01

2. Systemic inflammatory indices for predicting prognosis of myelofibrosis;Scientific Reports;2023-08-02

3. CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70—A Retrospective Study;Cancers;2023-02-25

4. Significance of C-reactive protein in patients with chronic myelomonocytic leukemia;Wiener Medizinische Wochenschrift;2022-11-28

5. Clinical and prognostic significance of C-reactive protein to albumin ratio in hospitalized coronavirus disease 2019 (COVID-19) patients;Wiener klinische Wochenschrift;2022-01-17